Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.320
+0.020 (1.54%)
At close: May 8, 2026, 4:00 PM EDT
1.310
-0.010 (-0.76%)
After-hours: May 8, 2026, 7:42 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $147.1 million as of May 8, 2026. Its market cap has increased by 64.86% in one year.
Market Cap
147.10M
Enterprise Value
131.55M
1-Year Change
64.86%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $147.10M, an increase of 110.84%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 147.10M | 54.72% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 329.32M |
| Aurora Cannabis | 209.21M |
| Anika Therapeutics | 201.18M |
| Organigram Global | 196.16M |
| Alpha Teknova | 195.14M |
| Lifecore Biomedical | 185.89M |
| Assertio Holdings | 143.30M |
| Journey Medical | 142.39M |